Test Pertuzumab (ZRC-3277)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Test Pertuzumab (ZRC-3277), covering 2024-07-18 to 2024-07-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,) [Phase 3]